Sprinklr, Inc. (CXM) stock
CXMNYSEServices-Prepackaged SoftwareFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 11/307% above fair value
$6.62−0.17 (-2.50%)
Close on Nov 17, 2026Market cap $1.54BP/E 66.2Yield –
Sprinklr r&d expenses
Research and development expenses are spending on new products and technology.
Sprinklr's R&D Expenses for the twelve months ending Jul 31, 2026 was $97.82M, up 6.5% year over year. For fiscal 2026 it was $96.00M, up 4.8% from the year before. The highest annual figure on record is $96.00M in fiscal 2026.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $96.00M | +4.8% |
| FY2025 | Jan 31, 2025 | $91.62M | +0.4% |
| FY2024 | Jan 31, 2024 | $91.29M | +19.1% |
| FY2023 | Jan 31, 2023 | $76.66M | +26.5% |
| FY2022 | Jan 31, 2022 | $60.59M | +50.4% |
| FY2021 | Jan 31, 2021 | $40.28M | +24.0% |
| FY2020 | Jan 31, 2020 | $32.48M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jul 31, 2026 | $24.43M | +5.5% |
| Q1 FY2027CQ1 2026 | Apr 30, 2026 | $23.36M | +2.4% |
| Q4 FY2026CQ4 2025 | Jan 31, 2026 | $25.32M | +12.2% |
| Q3 FY2026CQ3 2025 | Oct 31, 2025 | $24.71M | +6.0% |
| Q2 FY2026CQ2 2025 | Jul 31, 2025 | $23.16M | -0.3% |
| Q1 FY2026CQ1 2025 | Apr 30, 2025 | $22.81M | +1.2% |
| Q4 FY2025CQ4 2024 | Jan 31, 2025 | $22.56M | -2.2% |
| Q3 FY2025CQ3 2024 | Oct 31, 2024 | $23.30M | +0.7% |
| Q2 FY2025CQ2 2024 | Jul 31, 2024 | $23.23M | -4.5% |
| Q1 FY2025CQ1 2024 | Apr 30, 2024 | $22.54M | +8.6% |
| Q4 FY2024CQ4 2023 | Jan 31, 2024 | $23.06M | +14.6% |
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | $23.15M | +20.5% |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | $24.32M | +21.7% |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | $20.76M | +19.8% |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | $20.13M | +26.8% |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | $19.21M | +15.8% |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | $19.99M | +32.9% |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | $17.33M | +32.4% |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | $15.87M | +18.4% |
| Q3 FY2022CQ3 2021 | Oct 31, 2021 | $16.59M | +59.6% |
| Q2 FY2022CQ2 2021 | Jul 31, 2021 | $15.04M | +84.5% |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | $13.09M | – |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | $13.41M | – |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | $10.39M | – |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | $8.15M | – |
See a number that looks wrong?